Mmbg Investment Advisors CO. acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 22,563 shares of the company’s stock, valued at approximately $2,919,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. West Family Investments Inc. purchased a new position in Merck KGaA in the 2nd quarter valued at about $1,632,000. Knuff & Co LLC acquired a new position in shares of Merck KGaA in the second quarter valued at approximately $1,675,000. NewEdge Wealth LLC acquired a new position in shares of Merck KGaA in the second quarter valued at approximately $8,340,000. Empirical Asset Management LLC purchased a new position in shares of Merck KGaA during the second quarter valued at approximately $1,996,000. Finally, Chancellor Financial Group WB LP purchased a new position in shares of Merck KGaA during the second quarter valued at approximately $839,000. 0.10% of the stock is currently owned by hedge funds and other institutional investors.
Merck KGaA Stock Up 4.5%
Shares of OTCMKTS MKGAF opened at $167.38 on Thursday. The firm’s 50 day moving average price is $162.50 and its 200 day moving average price is $148.28. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a market cap of $21.63 billion, a P/E ratio of 25.55 and a beta of 0.96. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
